These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28993504)

  • 1. Precision Transplant Medicine: Biomarkers to the Rescue.
    Naesens M; Anglicheau D
    J Am Soc Nephrol; 2018 Jan; 29(1):24-34. PubMed ID: 28993504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of renal transplant outcome: where do we stand?
    Phelan PJ; Conlon PJ; Sparks MA
    J Nephrol; 2014 Jun; 27(3):247-56. PubMed ID: 24515316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association studies in kidney transplantation: Advantages and constraints.
    Yang J; Claas FHJ; Eikmans M
    Transpl Immunol; 2018 Aug; 49():1-4. PubMed ID: 29704558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Medicine and Personalized Approach to Renal Transplantation.
    Dafoe DC; Tantisattamo E; Reddy U
    Semin Nephrol; 2018 Jul; 38(4):346-354. PubMed ID: 30082055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klotho: A Promising Biomarker Closely Related to Kidney Transplant.
    Deng G; Liu D
    Exp Clin Transplant; 2018 Jun; 16(3):253-258. PubMed ID: 29676702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving Biomarkers toward Clinical Implementation in Kidney Transplantation.
    Menon MC; Murphy B; Heeger PS
    J Am Soc Nephrol; 2017 Mar; 28(3):735-747. PubMed ID: 28062570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and personalized medicine: a focus on kidney disease.
    Siwy J; Mischak H; Zürbig P
    Expert Rev Proteomics; 2019 Sep; 16(9):773-782. PubMed ID: 31441341
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
    Abuhelaiqa E; Friedlander R; Aull M; Putheti P; Sharma V; Suthanthiran M; Dadhania D
    Clin Transpl; 2016; 32():83-91. PubMed ID: 28564525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune monitoring and biomarkers to predict chronic allograft dysfunction.
    Mannon RB
    Kidney Int Suppl; 2010 Dec; (119):S59-65. PubMed ID: 21116320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney transplantation in patients with a prior heart transplant.
    Cassuto JR; Reese PP; Bloom RD; Doyle A; Goral S; Naji A; Abt PL
    Transplantation; 2010 Feb; 89(4):427-33. PubMed ID: 20177344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluid-based assays and precision medicine of cardiovascular diseases: the 'hope' for Pandora's box?
    Benincasa G; Mansueto G; Napoli C
    J Clin Pathol; 2019 Dec; 72(12):785-799. PubMed ID: 31611285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune monitoring in renal transplantation: The search for biomarkers.
    Danger R; Sawitzki B; Brouard S
    Eur J Immunol; 2016 Dec; 46(12):2695-2704. PubMed ID: 27861809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and risk assessment of steroid resistance in acute kidney transplant rejection.
    Rekers NV; de Fijter JW; Claas FH; Eikmans M
    Transpl Immunol; 2016 Sep; 38():3-14. PubMed ID: 27480047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal transplantation strengths and shortcomings.
    Ponticelli C
    J Nephrol; 2001; 14 Suppl 4():S1-6. PubMed ID: 11798139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
    Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
    Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine Approaches to Diabetic Kidney Disease: Tissue as an Issue.
    Gluck C; Ko YA; Susztak K
    Curr Diab Rep; 2017 May; 17(5):30. PubMed ID: 28364354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach.
    Zanoni F; Khairallah P; Kiryluk K; Batal I
    Semin Nephrol; 2022 Jan; 42(1):29-43. PubMed ID: 35618394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.